Compare SPDR Gold Trust (GLD) vs Nuvation Bio Inc. Class A Common Stock (NUVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SPDR Gold Trust vs Nuvation Bio Inc. Class A Common Stock — how do they compare? SPDR Gold Trust trades at $384.85 (market cap $139.66B), while Nuvation Bio Inc. Class A Common Stock trades at $5.03 (market cap $1.74B). The key difference: SPDR Gold Trust is far larger — about 80.3× Nuvation Bio Inc. Class A Common Stock's market cap, and SPDR Gold Trust is more actively traded (9,544,773 versus 9,289,619). Which is the better fit depends on your goals — on Pluang, investors hold SPDR Gold Trust for 74 Days and Nuvation Bio Inc. Class A Common Stock for 1 Days on average.
| GLD | NUVB | |
|---|---|---|
Market Cap | $139.66B | $1.74B |
Volume | 9,544,773 | 9,289,619 |
52-Week High | $495.90 | $9.54 |
52-Week Low | $362.32 | $3.41 |
Typical Hold Time | 74 Days | 1 Days |
Sector | — | Health |
Enterprise Value | — | $1.33B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GLD, the SPDR Gold Trust ETF, trades at $384.77 with a 2.37% daily gain amid bearish technical signals. The stock faces pressure from rising Treasury yields and Federal Reserve rate expectations, though recent weak employment data provided temporary support. Technical indicators show strong bearish momentum with moving averages signaling sell pressure, while oscillators remain neutral. The ETF is testing key resistance levels with support at $373-$377 and resistance at $380-$384.
The outlook remains cautious as gold faces headwinds from monetary policy tightening and dollar strength. While serving as a traditional inflation hedge, GLD's near-term performance depends on interest rate trajectory and safe-haven demand. Risks include further Fed hawkishness and declining institutional interest, though long-term diversification benefits persist for portfolio allocation.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About SPDR Gold Trust
GLD is the largest physically backed gold ETF in the world. It offers investors a cost-efficient and secure way to track the price of gold bullion without the need for physical storage.
Read more on GLD →About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →
